TVAX Biomedical

TVAX Biomedical is a developer of targeted cellular immunotherapies aimed at providing paradigm-shifting cancer treatments. The company's immunotherapy uses patients' own cells to generate cancer-killing cells that can destroy patients' cancer cells, including cancer stem cells as a treatment for childhood brain cancer, enabling healthcare providers to leverage improved clinical outcomes, low toxicity, and the potential to fundamentally transform cancer therapy.